Helminth antigens enable CpG-activated dendritic cells to inhibit the symptoms of collagen-induced arthritis through Foxp3+ regulatory T cells

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Carranza, Franco ^a   Falcón, Cristian Roberto ^a   Nuñez, Nicolás ^a   Knubel, Carolina ^a   Correa, Silvia Graciela ^a   Bianco, Ismael ^b   Maccioni, Mariana ^a   Fretes, Ricardo ^c   Triquell, María Fernanda ^c   Motrán, Claudia Cristina ^a   Cervi, Laura ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; FASCIOLA HEPATICA EXTRACT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PARASITE ANTIGEN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DISEASE SEVERITY; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, HELMINTH; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CATTLE; DENDRITIC CELLS; FASCIOLA HEPATICA; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; IMMUNIZATION; MALE; MICE; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES, REGULATORY; TISSUE THERAPY; TRANSFORMING GROWTH FACTOR BETA;

BOVINAE; FASCIOLA HEPATICA; MUS; VERMES;

EID: 84864335042     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040356     Document Type: Article

References (43)

1. Lubberts E, (2008) IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis? Cytokine 41: 84-91.
2. Firestein GS, (2003) Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
3. Breedveld FC, Combe B, (2011) Understanding emerging treatment paradigms in rheumatoid arthritis. Arthritis Res Ther 13: S3.
4. Khan S, Greenberg JD, Bhardwaj N, (2009) Dendritic cells as targets for therapy in rheumatoid arthritis. Nat Rev Rheumatol 5: 566-571.
5. Morelli AE, Thomson AW, (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7: 610-621.
6. Thomson AW, Robbins PD, (2008) Tolerogenic dendritic cells for autoimmune disease and transplantation. Ann Rheum Dis 67: iii90-96.
7. van Riet E, Hartgers FC, Yazdanbakhsh M, (2007) Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 212: 475-490.
8. Maizels R, (2007) Regulation of the immune system in metazoan parasite infections. Novartis Found Symp 281: 192-204; discussion 204-199.
9. Segura M, Su Z, Piccirillo C, Stevenson MM, (2007) Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression. Eur J Immunol 37: 1887-1904.
10. Hamilton CM, Dowling DJ, Loscher CE, Morphew RM, Brophy PM, et al. (2009) The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function. Infect Immun 77: 2488-2498.
11. Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH, (2009) Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 183: 1577-1586.
12. Falcon C, Carranza F, Martinez FF, Knubel CP, Masih DT, et al. (2010) Excretory-secretory products (ESP) from Fasciola hepatica induce tolerogenic properties in myeloid dendritic cells. Vet Immunol Immunopathol 137: 36-46.
13. Falcon CR, Carranza FA, Aoki P, Motran CC, Cervi L Adoptive Transfer of Dendritic Cells Pulsed With, (2012) Fasciola hepatica Antigens and Lipopolysaccharides Confers Protection Against Fasciolosis in Mice. J Infect Dis. 205: 506-514.
14. Cervi L, Rubinstein H, Masih DT, (1996) Involvement of excretion-secretion products from Fasciola hepatica inducing suppression of the cellular immune responses. Vet Parasitol 61: 97-111.
15. Bianco ID, Balsinde J, Beltramo DM, Castagna LF, Landa CA, et al. (2000) Chitosan-induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages. FEBS Lett 466: 292-294.
16. MacDonald AS, Straw AD, Bauman B, Pearce EJ, (2001) CD8- dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 167: 1982-1988.
17. Kudo Y, Boyd CA, (2000) Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim Biophys Acta 1500: 119-124.
18. Popov I, Li M, Zheng X, San H, Zhang X, et al. (2006) Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res Ther 8: R141.
19. Campbell IK, Kinkel SA, Drake SF, van Nieuwenhuijze A, Hubert FX, et al. (2009) Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis. Arthritis Rheum 60: 1683-1693.
20. Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, et al. (1988) Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol 140: 1477-1484.
21. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M, (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60: 1006-1019.
22. Horwitz DA, Zheng SG, Gray JD, (2008) Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 29: 429-435.
23. Puccetti P, Grohmann U, (2007) IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 7: 817-823.
24. Setiady YY, Coccia JA, Park PU, (2010) In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur J Immunol 40: 780-786.
25. Frick JS, Grunebach F, Autenrieth IB, (2010) Immunomodulation by semi-mature dendritic cells: a novel role of Toll-like receptors and interleukin-6. Int J Med Microbiol 300: 19-24.
26. Stoop JN, Robinson JH, Hilkens CM, (2011) Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models? Ann Rheum Dis 70: 1526-1533.
27. Sidhu M, Griffiths MM, Bradley DS, (2009) Vaccination with collagen-pulsed dendritic cells prevents the onset and reduces the disease severity in the mouse model of spontaneous polychondritis. Clin Exp Immunol 157: 350-358.
28. van Duivenvoorde LM, Louis-Plence P, Apparailly F, van der Voort EI, Huizinga TW, et al. (2004) Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. Arthritis Rheum 50: 3354-3364.
29. Adorini L, Giarratana N, Penna G, (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16: 127-134.
30. van Duivenvoorde LM, Han WG, Bakker AM, Louis-Plence P, Charbonnier LM, et al. (2007) Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol 179: 1506-1515.
31. Curotto de Lafaille MA, Lafaille JJ, (2009) Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30: 626-635.
32. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
33. Fallarino F, Grohmann U, (2011) Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions. Curr Med Chem 18: 2215-2221.
34. Park MJ, Min SY, Park KS, Cho YG, Cho ML, et al. (2008) Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Res Ther 10: R11.
35. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, et al. (2011) Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12: 870-878.
36. Belladonna ML, Orabona C, Grohmann U, Puccetti P, (2009) TGF-beta and kynurenines as the key to infectious tolerance. Trends Mol Med 15: 41-49.
37. Sojka DK, Huang YH, Fowell DJ, (2008) Mechanisms of regulatory T-cell suppression- a diverse arsenal for a moving target. Immunology 124: 13-22.
38. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat. Rev. Immunol 10(3): 170-81.
39. Gonzalez S, Flo M, Margenat M, Duran R, Gonzalez-Sapienza G, et al. (2009) A family of diverse Kunitz inhibitors from Echinococcus granulosus potentially involved in host-parasite cross-talk. PLoS One 4: e7009.
40. Brady MT, O'Neill SM, Dalton JP, Mills KHG, (1999) Fasciola hepatica Suppresses a Protective Th1 Response against Bordetella pertussis. Infect Immun 67: 5372-5378.
41. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6: 1133-1141.
42. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, et al. (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50: 380-386.
43. Harry RA, Anderson AE, Isaacs JD, Hilkens CM, (2010) Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis 69: 2042-2050.